10 Times You'll Have To Know About ADHD Medication Pregnancy > 자유게시판

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or keep ADHD medications during breastfeeding and pregnancy is a difficult decision for women suffering from the condition. There are few data on how exposure to ADHD for a long time could affect the fetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication in the uterus don't develop neurological developmental disorders like hearing loss or impaired vision seizures, febrile seizures, or IQ impairment. The authors acknowledge that more high quality research is needed.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication must weigh the benefits of taking it against the possible risks to the baby. Physicians do not have the data needed to make unequivocal recommendations but they can provide information regarding benefits and risks that can aid pregnant women in making informed decisions.

A study published in Molecular Psychiatry found that women who used ADHD medications used to treat adhd during their early pregnancy did not have a significantly higher risk of fetal cardiac malformations or major structural birth defects. Researchers used a large sample-based case control study to compare the incidence of major structural defects in infants born to mothers who used stimulants during pregnancy. Pediatric cardiologists and clinical geneticists reviewed the cases to ensure correct classification of the cases and to reduce the possibility of bias.

However, the study had its limitations. In particular, they were unable to distinguish the effects of the medication from the effects of the disorder that is underlying. This makes it difficult for researchers to establish whether the small associations observed among the exposed groups were due to medication use, or if they were affected by co-morbidities. The researchers did not examine the long-term effects for the offspring.

The study did show that infants whose mothers took ADHD medications during pregnancy were at a more risk of being admitted to the neonatal intensive care unit (NICU) than infants who whose mothers did not take any medication or had cut back on their medications prior to or during pregnancy. This was due to central nervous system disorders, and the higher risk of admission did not appear to be affected by the type of stimulant medications were used during pregnancy.

Women who were taking stimulant ADHD medication during pregnancy were also at an increased risk of having a caesarean section or having a child with an low Apgar score (less than 7). These increases appear to be unrelated to the type of medication used during pregnancy.

The researchers suggest that the risk of a small amount with the use of ADHD medications during the early stages of pregnancy could be offset by the greater benefit to both the mother and child of continuing treatment for the woman's disorder. Physicians should speak with their patients about this and as much as possible, assist them improve coping skills which could reduce the impact of her disorder in her daily functioning and her relationships.

Medication Interactions

As more women than ever before are being diagnosed with ADHD and treated with medication, the issue of whether to continue or stop treatment during pregnancy is a question that more and more doctors have to face. These decisions are frequently made without clear and reliable evidence. Instead, doctors must weigh their own knowledge in conjunction with the experiences of other doctors and the research that has been conducted on the subject.

Particularly, the subject of potential risks for the baby can be a challenge. The research on this subject is based on observations rather than controlled studies, and many of the findings are conflicting. Additionally, the majority of studies limit their analysis to live births, which can undervalue the serious teratogenic effects that can lead to abortion or termination of the pregnancy. The study presented in this journal club addresses these limitations by looking at data from both live and deceased births.

The conclusion: While some studies have found that there is a positive correlation between ADHD medications and the risk of certain birth defects, other studies have found no connection and the majority of studies show a neutral or even slight negative effect. In the end an accurate risk-benefit analysis is required in every instance.

It isn't easy, but not impossible for women with ADHD to stop taking their medication. In fact, in an article recently published in Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping adhd medication intuniv medication during pregnancy can cause depression, feelings of loneliness, and family conflict for those suffering from the disorder. Furthermore, a loss of medication can interfere with the ability to do work-related tasks and safely drive, which are important aspects of a normal life for many people suffering from ADHD.

She suggests women who are uncertain about whether to continue or discontinue medication due to their pregnancy should consider informing family members, friends, and coworkers on the condition, its effects on daily functioning, and on the advantages of staying on the current treatment plan. It can also aid in ensuring that the woman feels supported as she struggles with her decision. Some medications can pass through the placenta. If the patient decides not to take her ADHD medication while breastfeeding, it is crucial to be aware that the drug could be transferred to the infant.

Birth Defects and Risk of

As the use and use of ADHD medication to treat symptoms of attention deficit hyperactivity disorder (ADHD) is increasing, so does concern about the potential adverse effects of the drugs on foetuses. A recent study published in the journal Molecular Psychiatry adds to the existing knowledge on this subject. With two massive data sets, researchers were able to examine more than 4.3 million pregnancies and see whether stimulant medications increased the risk of birth defects. While the overall risk remains low, the researchers discovered that the first-trimester exposure to ADHD medications was associated with an increased risk of specific heart defects, such as ventriculoseptal defect (VSD).

The researchers of the study could not discover any link between early medication usage and congenital anomalies like facial deformities, or club feet. The results are in agreement with previous studies that have shown the existence of a slight, but significant increase in cardiac malformations for women who started taking ADHD medication prior to the time of the birth of their child. This risk increased during the latter part of pregnancy, when a lot of women decided to stop taking their medication.

Women who took ADHD medication in the first trimester were more likely to require a caesarean birth, have a low Apgar after delivery and have a baby who needed breathing assistance after birth. The researchers of the study were unable to eliminate bias due to selection because they limited the study to women who did not have any other medical conditions that might have contributed to the findings.

The researchers hope that their research will help inform the clinical decisions of physicians who encounter pregnant women. The researchers recommend that, while discussing the risks and benefits are crucial, the decision about whether to continue or stop medication should be in light of the severity of each woman's ADHD symptoms and the needs of the woman.

The authors also warn that while discontinuing the medications is an option, it is not an option to consider due to the high incidence of depression and other mental health problems for women who are expecting or postpartum. Further, the research suggests that women who decide to stop taking their medications are more likely to experience difficulties adjusting to life without them after the baby's arrival.

Nursing

It can be a stressful experience to become a mother. Women with ADHD who have to manage their symptoms while attending physician appointments, making preparations for the arrival of a child and adapting to new routines in the home can experience severe challenges. Many women choose to continue taking their ADHD medication during pregnancy.

The risk to nursing infant is low because the majority of stimulant medications is absorbed through breast milk at low levels. The amount of exposure to what Medications are Prescribed For adhd will vary based on the dosage and frequency types of adhd medication uk administration as well as the time of the day. Additionally, different medications enter the body of the baby differently through the gastrointestinal tract and breast milk and the impact of this on a newborn infant is not yet fully understood.

Due to the absence of research, some doctors might be tempted to stop taking stimulant medication during the pregnancy of a woman. It's a difficult choice for the woman, who must weigh the advantages of taking her medication as well as the potential risks to the embryo. In the meantime, until more information is available, GPs should ask all pregnant patients about their experience with ADHD and if they plan or are taking to take medication during the perinatal period.

A growing number of studies have proven that most women can safely continue taking their ADHD medication while they are pregnant and nursing. As a result, an increasing number of patients are choosing to do so and, in consultation with their doctor they have discovered that the benefits of keeping their current medication far outweigh any potential risks.

Women with ADHD who are planning to breastfeed should seek the advice of a specialist psychiatrist prior to becoming pregnant. They should discuss their medication with their doctor what medications are prescribed for adhd and discuss the advantages and disadvantages of continuing treatment, including non-pharmacological management strategies. Psychoeducation is also required to help women with ADHD recognize their symptoms and the underlying disorder and learn about treatments and to reinforce existing strategies for coping. This should include a multidisciplinary approach with the GP, obstetricians and psychiatry. The pregnancy counselling should consist of discussion of a management plan for both the mother and child, monitoring for signs of deterioration and when necessary, making adjustments to the medication regimen.